REFINE – Regulatory Science Framework for assessment of risk benefit ration of Nanomedicines and Biomaterials

Keyphrases

1. Rationing 100%
2. Risk-benefit 100%
3. Biomaterials 100%
4. Nanomedicine 100%
5. Regulatory Science 100%
6. Framework for Assessment 100%
7. Risk Assessment 100%
8. Scientific Framework 100%
9. Regulatory Issues 75%
10. Decision Tree 50%
11. Integrin 50%
12. Product-specific 50%
13. Spheroid Formation 50%
14. Stem Cells 50%
15. 3D Spheroids 50%
16. Recognition Process 50%
17. Nanostructures 50%
18. Stem Cell Niche 33%
19. Adult Stem Cells 33%
20. Hyperbranched Structure 33%
21. Europe 25%
22. Missing Data 25%
23. Efficient Strategy 25%
24. Decision Support System 25%
25. Fitting Method 25%
26. Quality Management System 25%
27. Data Required 25%
28. Technology Development 25%
29. Physiological Distribution 25%
30. Medical Products 25%
31. Benefit-risk Assessment 25%
32. Nanosimilars 25%
33. Borderline Products 25%
34. Medical Devices 25%
35. Physicochemical Properties 16%
36. Non-adherent 16%
37. Mesenchymal Stem Cells 16%
38. Carboxybetaine 16%
39. Human Mesenchymal Stem Cells (hMSCs) 16%
40. Biorecognition 16%
41. Fibroblast-like 16%
42. Biochemical Properties 16%
43. Substrate Type 16%
44. Size Reduction 16%
45. Amino Acid Sequence 16%
46. Stem Cell Spheroid 16%
47. Laminin 16%
48. Nanotopography 16%
49. Adhesion 16%
50. Extracellular Matrix Protein 1 (ECM1) 16%
51. YIGSR 16%
52. Natural Environment 16%
53. Synthetic Substrate 16%
54. In Vitro Study 16%
55. Binding Motif 16%
56. Receptor-mediated 16%
57. Hyperbranched Polylysine 16%
58. Specific Binding 16%
59. Dendron 16%